Skip to content

Clinical trials

Fatty Liver trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20143
20151
20191
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Uppsala University3
AstraZeneca2
Danderyd Hospital1
Eli Lilly and Company1
GlaxoSmithKline1
Göteborg University1
Newcastle University1
Region Skane1
Sahlgrenska University Hospital1
University Hospital, Linkoeping1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver14
Obesity6
Non-alcoholic Fatty Liver Disease5
Insulin Resistance3
Liver Cirrhosis3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Disease2
Dyslipidemias2
Hypertension2

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.